Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Opiaid
AddedFeb 16, 2024
UpdatedJun 18, 2026
Opiaid

Opiaid

Seed

OpiAID: Advanced wearable tech innovator for opioid abuse treatment and overdose prevention.

HQ
Wilmington, NC, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to combat opioid abuse, OpiAID focuses on developing advanced wearable technology to aid in the treatment and prevention of opioid overdoses. The company's core vision is to enhance patient care through data-driven insights derived from their AI-powered Recovery Intelligence Platform. OpiAID's primary product is an AI-enabled wearable device designed to detect biological indicators of overdose, providing timely intervention and support for individuals struggling with opioid use disorder.

Notable figures affiliated with OpiAID include experts in healthcare technology and AI, although specific names are not provided. The company has attracted attention from investors interested in innovative health tech solutions. Key achievements include the successful development and deployment of their wearable technology, which has shown promise in improving treatment outcomes for opioid use disorder. Overall, OpiAID is making a significant impact by leveraging advanced technology to address a critical public health issue.

Opiaid - Similar Companies

Resilient Lifescience logo

Resilient Lifescience

resilient.bio

Behaivior logo

Behaivior

behaivior.com

OpiSafe logo

OpiSafe

opisafe.com

OPiO logo

OPiO

opioconnect.com

Opos logo

Opos

opos.solutions

OxiWear logo

OxiWear

oxiwear.com

Respira Labs logo

Respira Labs

PranaQ logo

PranaQ

pranaq.com

Zeit Medical logo

Zeit Medical

zeitmedical.com

Ophelia logo

Ophelia

ophelia.com

Cogwear logo

Cogwear

cogweartech.com

Stat Health logo

Stat Health

stat-health.com

Alio logo

Alio

alio.ai

Celero Systems logo

Celero Systems

celerosystems.com

Awake Labs logo

Awake Labs

awakelabs.com

Opiaid - Quick Facts

Who are Opiaid's competitors?

Companies similar to Opiaid include Resilient Lifescience, Behaivior, OpiSafe and OPiO.

When was Opiaid founded?

Opiaid was founded in 2018.

Where is Opiaid's headquarters located?

Opiaid's headquarters is located in Wilmington, NC, US.

When was Opiaid's last funding round?

Opiaid's most recent funding round was for $2.8M (USD) in May 2023.

How much has Opiaid raised to-date?

As of May 3, 2023, Opiaid has raised a total of $3.2M (USD).

How many employees does Opiaid have?

Opiaid has 13 employees as of Feb 4, 2024.

Opiaid - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Wearable Technology
Tags
  • AI Operations
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 9 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified